Fiera Capital (Canada)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,356
| Closed | -$605K | – | 758 |
|
|
2018
Q3 | $605K | Sell |
4,356
-69
| -2% | -$9.58K | ﹤0.01% | 538 |
|
|
2018
Q2 | $549K | Sell |
4,425
-35
| -0.8% | -$4.34K | ﹤0.01% | 535 |
|
|
2018
Q1 | $497K | Sell |
4,460
-3,125
| -41% | -$348K | ﹤0.01% | 509 |
|
|
2017
Q4 | $907K | Sell |
7,585
-62,505
| -89% | -$7.47M | ﹤0.01% | 445 |
|
|
2017
Q3 | $9.83M | Buy |
+70,090
| New | +$9.83M | 0.05% | 238 |
|
|
2015
Q3 | – | Sell |
-1,500
| Closed | -$271 | – | 578 |
|
|
2015
Q2 | $271 | Buy |
+1,500
| New | +$271 | ﹤0.01% | 496 |
|
|
2014
Q4 | – | Sell |
-1,300
| Closed | -$216K | – | 462 |
|
|
2014
Q3 | $216K | Sell |
1,300
-500
| -28% | -$83.1K | ﹤0.01% | 441 |
|
|
2014
Q2 | $281K | Sell |
1,800
-6,100
| -77% | -$952K | ﹤0.01% | 469 |
|
|
2014
Q1 | $1.2M | Sell |
7,900
-4,000
| -34% | -$609K | 0.01% | 413 |
|
|
2013
Q4 | $1.58M | Buy |
11,900
+10,000
| +526% | +$1.33M | 0.01% | 382 |
|
|
2013
Q3 | $221K | Buy |
+1,900
| New | +$221K | ﹤0.01% | 343 |
|